Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.845,08
-0,07%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

Applied Therapeutics Inc

APLT
4,76
0,23 (5,08%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/4/202413:00GLOBEApplied Therapeutics Appoints Dale Hooks as Chief Commercial..
04/4/202413:00GLOBEApplied Therapeutics to Present Results from Phase 3..
28/3/202421:30GLOBEApplied Therapeutics Provides FDA Update on PDUFA Target..
11/3/202413:17EDGAR2Form 8-K - Current report
06/3/202413:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:12EDGAR2Form 8-K - Current report
06/3/202413:00GLOBEApplied Therapeutics Reports Fourth Quarter and Year-end..
05/3/202423:42EDGAR2Form SC 13D/A - General statement of acquisition of..
29/2/202422:18EDGAR2Form 8-K - Current report
28/2/202414:05GLOBEApplied Therapeutics Announces $100 Million Private..
28/2/202414:00GLOBEApplied Therapeutics Announces FDA Acceptance and Priority..
22/2/202420:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202413:07EDGAR2Form 8-K - Current report
15/2/202413:00GLOBEApplied Therapeutics Announces Positive Results from..
15/2/202403:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202423:02EDGAR2Form 8-K - Current report
04/1/202422:05GLOBEApplied Therapeutics Announces Topline Results from the..
03/1/202417:20DJNApplied Therapeutics Shares Hit 52-Week High on Govorestat..
03/1/202415:15EDGAR2Form 8-K - Current report
03/1/202413:00GLOBEApplied Therapeutics Announces MAA Validation and NDA..
29/12/202322:23EDGAR2Form 8-K - Current report
23/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:11EDGAR2Form 8-K - Current report
13/11/202323:10EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202313:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:36EDGAR2Form 8-K - Current report
09/11/202313:30GLOBEApplied Therapeutics Reports Third Quarter 2023 Financial..
03/11/202321:37EDGAR2Form 144 - Report of proposed sale of securities
02/11/202321:33EDGAR2Form 144 - Report of proposed sale of securities
02/11/202312:00GLOBEApplied Therapeutics to Present at the UBS Biopharma..
01/11/202321:42EDGAR2Form 144 - Report of proposed sale of securities
01/11/202312:00GLOBEApplied Therapeutics to Host Diabetic Cardiomyopathy Expert..
31/10/202321:42EDGAR2Form 144 - Report of proposed sale of securities
13/10/202322:42EDGAR2Form 8-K - Current report
30/9/202302:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202313:00GLOBEApplied Therapeutics to Present Baseline Data from Phase 3..
06/9/202317:08DJNApplied Therapeutics Shares Rise 11% After Pre-NDA Meeting..
06/9/202313:12EDGAR2Form 8-K - Current report
06/9/202313:00GLOBEApplied Therapeutics Announces Successful Pre-NDA Meeting..
11/8/202322:50EDGAR2Form 8-K - Current report
Apertura: 4,63 Min: 4,605 Max: 4,86
Chiusura: 4,53

La tua Cronologia

NASDAQ
APLT
Applied Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network